Pharmaceuticals should be recognised as a priority sector We consider that critical medicines and their inputs should be expressly included among the priority value chains, notably: active pharmaceutical ingredients (APIs) and key starting materials; critical excipients and biological raw materials sterile primary packaging and medical device components.
LFR
LABORATORIOS FARMACEUTICOS ROVI S.A
Company · Spain · EU Transparency Register 399928552868-09
1
position filed
in the 687 files tracked
1
legislative file
of 687 tracked
0
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 687 consultation files tracked so far (60,344 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1244 companies & groups on this site, they rank #1077 by legislative files engaged, a count of participation, not a measure of influence.
0.5
declared lobbying FTE
self-declared
< €10K
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2024
in the register since
Declares membership of
- Biosim (Asociación Española de Medicamentos Biosimilares), que es la asociación española que engloba a las empresas f…
- Fundación IDIS, entidad que aglutina al sector sanitario privado orientado a poner en valor la sanidad privada (es mu…
- Farmaindustria →
- AKG en Alemania
- Apifarma en Portugal
- EFPIA →
- Corporación Tecnológica CTA
- Fenin
- Federación Española de Empresas de Tecnología Sanitaria
- que trabaja para impulsar la innovación
- calidad y sostenibilidad del sector de tecnología sanitaria en España.
Self-declared to the EU Transparency Register (snapshot 27 Oct 2026).
- Register category
- Companies & groups
- Registered as
- Laboratorios Farmacéuticos Rovi, S.A.
- Head office
- Madrid, Spain
Self-declared to the EU Transparency Register (snapshot 27 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track LABORATORIOS in PolicySpeak: request access →
Work at LABORATORIOS FARMACEUTICOS ROVI S.A? so we know who speaks for it.
Their record over time
LABORATORIOS FARMACEUTICOS ROVI S.A filed 1 position on 26 Oct 2026, across 1 of the 687 legislative files tracked here.
What they argued
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put LABORATORIOS FARMACEUTICOS ROVI S.A next to another organization. Same files, same register facts, side by side. Compare →
Is this your organization?
Everything on this page comes from LABORATORIOS FARMACEUTICOS ROVI S.A’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.